Infectious Risks of Air Travel.
Identifieur interne : 001399 ( PubMed/Corpus ); précédent : 001398; suivant : 001400Infectious Risks of Air Travel.
Auteurs : Alexandra Mangili ; Tine Vindenes ; Mark GendreauSource :
- Microbiology spectrum [ 2165-0497 ] ; 2015.
English descriptors
- KwdEn :
- MESH :
- transmission : Communicable Diseases.
- Air Travel, Disease Transmission, Infectious, Global Health, Humans, Risk Assessment.
Abstract
Infectious diseases are still among the leading causes of death worldwide due to their persistence, emergence, and reemergence. As the recent Ebola virus disease and MERS-CoV outbreaks demonstrate, the modern epidemics and large-scale infectious outbreaks emerge and spread quickly. Air transportation is a major vehicle for the rapid spread and dissemination of communicable diseases, and there have been a number of reported outbreaks of serious airborne diseases aboard commercial flights including tuberculosis, severe acute respiratory syndrome, influenza, smallpox, and measles, to name a few. In 2014 alone, over 3.3 billion passengers (a number equivalent to 42% of the world population) and 50 million metric tons of cargo traveled by air from 41,000 airports and 50,000 routes worldwide, and significant growth is anticipated, with passenger numbers expected to reach 5.9 billion by 2030. Given the increasing numbers of travelers, the risk of infectious disease transmission during air travel is a significant concern, and this chapter focuses on the current knowledge about transmission of infectious diseases in the context of both transmissions within the aircraft passenger cabin and commercial aircraft serving as vehicles of worldwide infection spread.
DOI: 10.1128/microbiolspec.IOL5-0009-2015
PubMed: 26542037
Links to Exploration step
pubmed:26542037Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Infectious Risks of Air Travel.</title><author><name sortKey="Mangili, Alexandra" sort="Mangili, Alexandra" uniqKey="Mangili A" first="Alexandra" last="Mangili">Alexandra Mangili</name><affiliation><nlm:affiliation>Department of Infectious Disease, Tufts University, Boston, MA 02111.</nlm:affiliation></affiliation></author><author><name sortKey="Vindenes, Tine" sort="Vindenes, Tine" uniqKey="Vindenes T" first="Tine" last="Vindenes">Tine Vindenes</name><affiliation><nlm:affiliation>Tufts Medical Center, Boston, MA 02111.</nlm:affiliation></affiliation></author><author><name sortKey="Gendreau, Mark" sort="Gendreau, Mark" uniqKey="Gendreau M" first="Mark" last="Gendreau">Mark Gendreau</name><affiliation><nlm:affiliation>Lahey Clinic, Burlington, MA 01805.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26542037</idno><idno type="pmid">26542037</idno><idno type="doi">10.1128/microbiolspec.IOL5-0009-2015</idno><idno type="wicri:Area/PubMed/Corpus">001399</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001399</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Infectious Risks of Air Travel.</title><author><name sortKey="Mangili, Alexandra" sort="Mangili, Alexandra" uniqKey="Mangili A" first="Alexandra" last="Mangili">Alexandra Mangili</name><affiliation><nlm:affiliation>Department of Infectious Disease, Tufts University, Boston, MA 02111.</nlm:affiliation></affiliation></author><author><name sortKey="Vindenes, Tine" sort="Vindenes, Tine" uniqKey="Vindenes T" first="Tine" last="Vindenes">Tine Vindenes</name><affiliation><nlm:affiliation>Tufts Medical Center, Boston, MA 02111.</nlm:affiliation></affiliation></author><author><name sortKey="Gendreau, Mark" sort="Gendreau, Mark" uniqKey="Gendreau M" first="Mark" last="Gendreau">Mark Gendreau</name><affiliation><nlm:affiliation>Lahey Clinic, Burlington, MA 01805.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Microbiology spectrum</title><idno type="eISSN">2165-0497</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Air Travel</term><term>Communicable Diseases (transmission)</term><term>Disease Transmission, Infectious</term><term>Global Health</term><term>Humans</term><term>Risk Assessment</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Communicable Diseases</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Air Travel</term><term>Disease Transmission, Infectious</term><term>Global Health</term><term>Humans</term><term>Risk Assessment</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Infectious diseases are still among the leading causes of death worldwide due to their persistence, emergence, and reemergence. As the recent Ebola virus disease and MERS-CoV outbreaks demonstrate, the modern epidemics and large-scale infectious outbreaks emerge and spread quickly. Air transportation is a major vehicle for the rapid spread and dissemination of communicable diseases, and there have been a number of reported outbreaks of serious airborne diseases aboard commercial flights including tuberculosis, severe acute respiratory syndrome, influenza, smallpox, and measles, to name a few. In 2014 alone, over 3.3 billion passengers (a number equivalent to 42% of the world population) and 50 million metric tons of cargo traveled by air from 41,000 airports and 50,000 routes worldwide, and significant growth is anticipated, with passenger numbers expected to reach 5.9 billion by 2030. Given the increasing numbers of travelers, the risk of infectious disease transmission during air travel is a significant concern, and this chapter focuses on the current knowledge about transmission of infectious diseases in the context of both transmissions within the aircraft passenger cabin and commercial aircraft serving as vehicles of worldwide infection spread. </div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26542037</PMID><DateCompleted><Year>2016</Year><Month>08</Month><Day>11</Day></DateCompleted><DateRevised><Year>2018</Year><Month>08</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2165-0497</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>5</Issue><PubDate><Year>2015</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Microbiology spectrum</Title><ISOAbbreviation>Microbiol Spectr</ISOAbbreviation></Journal><ArticleTitle>Infectious Risks of Air Travel.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1128/microbiolspec.IOL5-0009-2015</ELocationID><Abstract><AbstractText>Infectious diseases are still among the leading causes of death worldwide due to their persistence, emergence, and reemergence. As the recent Ebola virus disease and MERS-CoV outbreaks demonstrate, the modern epidemics and large-scale infectious outbreaks emerge and spread quickly. Air transportation is a major vehicle for the rapid spread and dissemination of communicable diseases, and there have been a number of reported outbreaks of serious airborne diseases aboard commercial flights including tuberculosis, severe acute respiratory syndrome, influenza, smallpox, and measles, to name a few. In 2014 alone, over 3.3 billion passengers (a number equivalent to 42% of the world population) and 50 million metric tons of cargo traveled by air from 41,000 airports and 50,000 routes worldwide, and significant growth is anticipated, with passenger numbers expected to reach 5.9 billion by 2030. Given the increasing numbers of travelers, the risk of infectious disease transmission during air travel is a significant concern, and this chapter focuses on the current knowledge about transmission of infectious diseases in the context of both transmissions within the aircraft passenger cabin and commercial aircraft serving as vehicles of worldwide infection spread. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mangili</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease, Tufts University, Boston, MA 02111.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vindenes</LastName><ForeName>Tine</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Tufts Medical Center, Boston, MA 02111.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gendreau</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Lahey Clinic, Burlington, MA 01805.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Microbiol Spectr</MedlineTA><NlmUniqueID>101634614</NlmUniqueID><ISSNLinking>2165-0497</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D064870" MajorTopicYN="Y">Air Travel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003141" MajorTopicYN="N">Communicable Diseases</DescriptorName><QualifierName UI="Q000635" MajorTopicYN="Y">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018562" MajorTopicYN="Y">Disease Transmission, Infectious</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26542037</ArticleId><ArticleId IdType="doi">10.1128/microbiolspec.IOL5-0009-2015</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001399 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001399 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:26542037
|texte= Infectious Risks of Air Travel.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:26542037" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |